Melatonin and Adiponectin in Hypertensive Kidney Transplant
Recently we have shown that melatonin secretion is impaired in rats with metabolic syndrome. We have also demonstrated that exogenic melatonin supplementation can improve blood pressure profile in nondipper patients.
The aim of this study is to find whether there is a difference between melatonin secretion in hypertensive kidney recipients versus "normal" hypertensive patients. Secondly, to ask if there is any correlation between melatonin secretion and adiponectin levels.
|Study Design:||Observational Model: Case Control
Time Perspective: Prospective
|Study Start Date:||September 2007|
kidney transplant with hypertension
hypertensive patients with native kidneys
Please refer to this study by its ClinicalTrials.gov identifier: NCT00498576
|Sheba Medical Center|
|Principal Investigator:||Avshalom Leibowitz, MD|